LP429469-2BrexpiprazoleActive
Description
LP429469-2 Brexpiprazole
Brexpiprazole is known as 'atypical' antipsychotic drug approved by the FDA in July 2015 for treatment of schizophrenia and adjunctive therapy for major depressive disorder. [PMID:PMC6007711]
Source: Regenstrief LOINC
Basic Part Properties
- Name
- Brexpiprazole
- Type
- Component
- Created On
- 2021-09-03
- Construct for LOINC Short Name
- Brexpiprazole
LOINC FHIR® API Example - CodeSystem Request Get Info
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP429469-2
Language Variants Get Info
- zh-CNChinese (China)
- 依匹哌唑
Synonyms: OPC-34712;CAS 913611-97-9; Rexulti; 布瑞哌唑 - nl-NLDutch (Netherlands)
- brexpiprazol
- it-ITItalian (Italy)
- Brexpiprazolo
- es-ESSpanish (Spain)
- Brexpiprazol
LOINC Copyright
Copyright © 2022 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright